Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   


The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (

go back to main search page
Accession:XCO:0000684 term browser browse the term
Definition:A condition in which the main influencing factor is nateglinide, an N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid. An orally-administered, rapidly-absorbed, short-acting insulinotropic agent, it is used for the treatment of type 2 diabetes mellitus.
Synonyms:exact_synonym: N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine
 xref: CHEBI:31897

show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "nateglinide" (XCO:0000684)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    chemical 707
      chemical with specified function 434
        hypoglycemic agent 0
          nateglinide 0
paths to the root